Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelomas”

3,922 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,922 results

Not applicableUnknownNCT05414162
What this trial is testing

Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy

Who this might be right for
DLBCLMultiple MyelomaCytokine Release Syndrome+6 more
University Hospital, Bonn 60
Testing effectiveness (Phase 2)Ended earlyNCT01832727
What this trial is testing

Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Amgen 65
Testing effectiveness (Phase 2)Looking for participantsNCT04973605
What this trial is testing

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
BeOne Medicines 246
Early research (Phase 1)Study completedNCT00400556
What this trial is testing

ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells

Who this might be right for
Multiple MyelomaCutaneous Lymphoma
Peter MacCallum Cancer Centre, Australia 6
Not applicableLooking for participantsNCT03131531
What this trial is testing

Bergamo Lymphoid Cancer Registry

Who this might be right for
Hodgkin LymphomaNon Hodgkin LymphomaMyeloma
A.O. Ospedale Papa Giovanni XXIII 6,000
Early research (Phase 1)Study completedNCT00083460
What this trial is testing

Study of Combination PS-341 and Thalidomide in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 86
Large-scale testing (Phase 3)Active Not RecruitingNCT05083169
What this trial is testing

Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 587
Not applicableLooking for participantsNCT06697483
What this trial is testing

Risk Stratification and MRD-driven Maintenance for MM After ASCT

Who this might be right for
Multiple Myeloma
Peking University People's Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT04465760
What this trial is testing

Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy

Who this might be right for
LymphomaMalignant Solid NeoplasmPlasma Cell Myeloma
OHSU Knight Cancer Institute 9
Testing effectiveness (Phase 2)Ended earlyNCT03333746
What this trial is testing

Lenalidomide and Nivolumab in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Yvonne Efebera 1
Early research (Phase 1)Ended earlyNCT05698888
What this trial is testing

Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors

Who this might be right for
Solid Tumors, AdultMultiple MyelomaLymphoma
Virtuoso BINco, Inc. 2
Testing effectiveness (Phase 2)Study completedNCT00079456
What this trial is testing

Temsirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
National Cancer Institute (NCI) 25
Early research (Phase 1)Study completedNCT00255710
What this trial is testing

Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Not applicableNot Yet RecruitingNCT06472479
What this trial is testing

LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
The First Affiliated Hospital with Nanjing Medical University 66
Testing effectiveness (Phase 2)UnknownNCT03336073
What this trial is testing

Carfilzomib, Cyclophosphamide, Dexamethasone in Multiple Myeloma

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 199
Testing effectiveness (Phase 2)Study completedNCT00003270
What this trial is testing

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Roswell Park Cancer Institute 20
Not applicableEnded earlyNCT00514722
What this trial is testing

Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+7 more
University of California, San Francisco 4
Not applicableUnknownNCT03302403
What this trial is testing

Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors

Who this might be right for
B Cell LymphomaB Cell LeukemiaMyeloma+3 more
Kang YU 18
Early research (Phase 1)Study completedNCT03311828
What this trial is testing

Copper 64Cu-DOTA-Daratumumab Positron Emission Tomography in Diagnosing Patients With Relapsed Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaPlasma Cell MyelomaSecondary Amyloidosis
City of Hope Medical Center 12
Early research (Phase 1)Study completedNCT00006098
What this trial is testing

PS-341 in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Memorial Sloan Kettering Cancer Center
Load More Results